MedPath

Adductor Canal Block for Medial Compartment Knee Arthroplasty

Phase 4
Completed
Conditions
Postoperative Analgesia
Medial Unicompartmental Knee Arthroplasty
Interventions
Drug: Adductor canal block
Drug: Lumbar plexus block
Registration Number
NCT01818531
Lead Sponsor
Wake Forest University Health Sciences
Brief Summary

This study will evaluate the affects of a single injection ultrasound-guided adductor canal block for patients undergoing robotic-assisted (MAKOplasty) medial UKA (unicompartmental knee arthroplasty). Specifically, this study will compare the adequacy of postoperative analgesia provided by the adductor canal block with that provided by single injection lumbar plexus blockade. The working hypothesis is that the analgesia provided by the adductor canal block will be equivalent to the analgesia provided by the lumbar plexus block. The primary outcome will be a comparison of verbal numerical pain scores at rest and with movement over the first 24 hours following nerve blockade.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
150
Inclusion Criteria
  • Patients aged 18-85
  • Undergoing unilateral robotic-assisted (MAKOplasty) medial compartment knee arthroplasty at Wake Forest University Baptist Medical Center.
  • Must give written informed consent for anesthesia including subarachnoid blockade and peripheral nerve blockade of both the lumbar plexus and adductor canal.
  • Must consent to the performance of a sham block at the site to which they are not randomized.
  • Must also be reliable to give accurate verbal pain scores postoperatively.
Read More
Exclusion Criteria
  • Contraindication to adductor canal blockade or lumbar plexus blockade (including significant coagulation abnormalities)
  • History of opioid addiction or current chronic pain therapy for pain other than at the surgical site that is being treated with high-dose opioids (extended release opioids or > 40mg oxycodone equivalents per day)
  • Allergy to study medications
  • Failure to adequately place either the adductor canal or lumbar plexus blocks.
  • Patients who decline or have a contraindication to subarachnoid blockade will also be excluded from the study.
  • Pregnancy.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Adductor canal blockAdductor canal blockPatients in this arm will receive an adductor canal block prior to undergoing a medial compartment knee arthroplasty.
Lumbar plexus blockLumbar plexus blockPatients in this arm will receive a lumbar plexus block prior to undergoing a medial compartment knee arthroplasty.
Primary Outcome Measures
NameTimeMethod
Verbal Pain Scores at 6 Hours Post Nerve Blockade.6 hours post block.

Comparison of verbal numerical pain scores at rest and with movement 6 hours following nerve blockade. The score range is 0-10 with higher scores denoting worse outcomes.

Secondary Outcome Measures
NameTimeMethod
Quadriceps Motor Strength6 hours

Comparison of quadriceps motor strength at 6 hour post nerve block between two groups: adductor canal block and lumbar plexus block. The score range is 0-5, with higher scores denoting better outcomes.

Opioid Related Side Effects6, 12, 18, and 24 hours

Occurrence of opioid related side effects (nausea, vomiting and pruritus) between two groups: adductor canal block and lumbar plexus block.

Opioid Consumption6, 12, 18, and 24 hours

Comparison of cumulative opioid consumption over 24 hour period between adductor canal block and lumbar plexus block.

Time to First Analgesic24 hours

Time to first analgesic between two groups: adductor canal block and lumbar plexus block.

Trial Locations

Locations (1)

Wake Forest University Baptist Medical Center

🇺🇸

Winston-Salem, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath